A review of the pathogenesis of mitochondria in breast cancer and progress of targeting mitochondria for breast cancer treatment
Abstract With breast cancer being the most common tumor among women in the world today, it is also the leading cause of cancer-related deaths. Standard treatments include chemotherapy, surgery, endocrine therapy, and targeted therapy. However, the heterogeneity, drug resistance, and poor prognosis o...
Saved in:
Main Authors: | Aoling Huang, Haochen Xue, Ting Xie, Lingyan Xiang, Zhengzhuo Chen, Aolong Ma, Honglin Yan, Jingping Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-025-06077-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Situ Transformable Nanoparticle Effectively Suppresses Bladder Cancer by Damaging Mitochondria and Blocking Mitochondrial Autophagy Flux
by: Yulin Lv, et al.
Published: (2025-02-01) -
Telomerase and mitochondria inhibition promote apoptosis and TET2 and ANMT3a expression in triple negative breast cancer cell lines
by: Zeinab Mazloumi, et al.
Published: (2024-07-01) -
The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy
by: Ryosuke Takegawa, et al.
Published: (2025-01-01) -
Identification and validation of a prognostic signature of drug resistance and mitochondrial energy metabolism-related differentially expressed genes for breast cancer
by: Tiankai Xu, et al.
Published: (2025-01-01) -
Unraveling the genetic connections for mitochondrial DNA control region and breast cancer susceptibility
by: Namra Khalid, et al.
Published: (2025-02-01)